宫颈癌前病变检测：HPV检测优于Pap检测

在检测宫颈部癌前病变方面，人乳头瘤病毒(HPV)检测方法比传统的Pap斑点法更加敏感。

既往研究显示使用HPB检测癌前宫颈病变-上皮内新生物－方面更加敏感，但是假阳性比传统的Pap斑点法要高，医生使用该方法在切片上寻找异常细胞。液相细胞学是一种更为新颖的Pap技术，在寻找细胞之前医生首先将Pap样本浸入溶液中。一项最新研究对比了这些检测方法在发现癌前宫颈病变的能力，研究结果发表在2006年7月7日的《国家癌症研究院期刊》之上。

研究结果显示在23-60岁女性中，单独使用HPV检测就比Pap斑点法更加敏感。补充使用液相细胞学检测只能够部分提高敏感性但是同时增加了假阳性。

HPV Test Better Than Pap Test
 
Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions in the cervix.

Previous studies have shown that searching for a precancerous cervical lesion called cervical intraepithelial neoplasma using an HPV test is more sensitive but has more false-positives than conventional Pap smears, where doctors look for abnormal cells on a slide. Liquid-based cytology is a newer Pap technology where the doctors first immerse the Pap sample in a solution before looking at the cells. A new study comparing the ability of these tests to discover precancerous cervical lesions was reported in the June 7, 2006, issue of the Journal of the National Cancer Institute.

The results showed that HPV testing alone was more sensitive than Pap smears among women 35-60 years old. Adding liquid-based cytology improved sensitivity only marginally but increased false-positives.